Scientific Publications Search Search Author Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Falcke, Martin Prof. Dr. (18) Janz, Martin Dr. (6) Kettenmann, Helmut Prof. Dr. (1) Schmitt, Clemens Prof. Dr. (1) Specker, Edgar Dr. (1) von Kries, Jens Peter Dr. (1) (-) Mathas, Stephan Dr. (9) (-) Pezzutto, Antonio Prof. Dr. (1) 1999 (1) 2000 (1) 2001 (1) 2002 (5) 2003 (1) 2004 (2) 2005 (2) 2006 (4) (-) 2007 (3) 2008 (4) 2009 (3) (-) 2010 (3) 2011 (5) 2012 (1) 2013 (1) 2014 (2) 2015 (5) 2016 (2) (-) 2017 (3) 2018 (2) 2019 (2) 2020 (3) 2021 (3) 2022 (4) 2024 (1) (-) Biology of Malignant Lymphomas (9) Cancer Genetics and Cellular Stress Responses (1) Cardiac MRI (1) Experimental Ultrahigh-Field MR (3) Intracellular Proteolysis (1) Magnetic Resonance (3) Mathematical Modelling of Cellular Processes (5) Microenvironmental Regulation in Autoimmunity and Cancer (1) Molecular Immunology and Gene Therapy (1) Molecular Physiology of Somatic Sensation (5) Neural Circuits and Behaviour (1) Non-coding RNAs and Mechanisms of Cytoplasmic Gene Regulation (1) Protein Production and Characterization (1) Proteome Dynamics (2) Proteomics and Metabolomics (1) Structural Biology of Membrane-Associated Processes (1) Translational Cardiology and Functional Genomics (1) 9 Results: Active Filter: Mathas, Stephan Dr.Pezzutto, Antonio Prof. Dr.Biology of Malignant Lymphomas200720102017 Sort: Result score Newest to oldest Oldest to newest March 01, 2007 / Hum Immunol Dendritic cell maturation stage determines susceptibility to the proteasome inhibitor bortezomib M. Subklewe K. Sebelin-Wulf C. Beier A. Lietz S. Mathas B. Doerken A. Pezzutto May 01, 2007 / Br J Haematol Loss of bHLH transcription factor E2A activity in primary effusion lymphoma confers resistance to apoptosis A. Lietz M. Janz M. Sigvardsson F. Jundt B. Doerken S. Mathas October 01, 2007 / Hematol Oncol Clin North Am The pathogenesis of classical Hodgkin's lymphoma: a model for B-cell plasticity S. Mathas November 01, 2010 / Cell Cycle Repeat-element driven activation of proto-oncogenes in human malignancies B. Lamprecht C. Bonifer S. Mathas September 01, 2010 / Haematologica Common clonal origin of an acute B lymphoblastic leukemia and a Langerhans' cell sarcoma: evidence for hematopoietic plasticity R. Ratei M. Hummel I. Anagnostopoulos D. Jaehne R. Arnold B. Doerken S. Mathas B. Thomas O. Dudeck W.D. Ludwig H. Stein May 01, 2010 / Nat Med Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma B. Lamprecht K. Walter S. Kreher R. Kumar M. Hummel D. Lenze K. Koechert M.A. Bouhlel J. Richter E. Soler R. Stadhouders K. Joehrens K.D. Wurster D.F. Callen M.F. Harte M. Giefing R. Barlow H. Stein I. Anagnostopoulos M. Janz P.N. Cockerill R. Siebert B. Doerken C. Bonifer S. Mathas March 01, 2017 / Leukemia Inactivation of the putative ubiquitin-E3 ligase PDLIM2 in classical Hodgkin and anaplastic large cell lymphoma K.D. Wurster F. Hummel J. Richter M. Giefing S. Hartmann M.L. Hansmann S. Kreher K. Köchert D. Krappmann W. Klapper M. Hummel S.S. Wenzel G. Lenz M. Janz B. Dörken R. Siebert S. Mathas January 05, 2017 / Blood Pharmacological restoration and therapeutic targeting of the B-cell phenotype in classical Hodgkin's lymphoma J. Du M. Neuenschwander Y. Yu J.H.M. Däbritz N.R. Neuendorff K. Schleich A. Bittner M. Milanovic G. Beuster S. Radetzki E. Specker M. Reimann F. Rosenbauer S. Mathas P. Lohneis M. Hummel B. Dörken J.P. von Kries S. Lee C.A. Schmitt December 01, 2017 / Lancet Oncol Incorporation of brentuximab vedotin into first-line treatment of advanced classical Hodgkin's lymphoma: final analysis of a phase 2 randomised trial by the German Hodgkin Study Group D.A. Eichenauer A. Plütschow S. Kreissl M. Sökler J.C. Hellmuth J. Meissner S. Mathas M.S. Topp K. Behringer W. Klapper G. Kuhnert M. Dietlein C. Kobe M. Fuchs V. Diehl A. Engert P. Borchmann
March 01, 2007 / Hum Immunol Dendritic cell maturation stage determines susceptibility to the proteasome inhibitor bortezomib M. Subklewe K. Sebelin-Wulf C. Beier A. Lietz S. Mathas B. Doerken A. Pezzutto
May 01, 2007 / Br J Haematol Loss of bHLH transcription factor E2A activity in primary effusion lymphoma confers resistance to apoptosis A. Lietz M. Janz M. Sigvardsson F. Jundt B. Doerken S. Mathas
October 01, 2007 / Hematol Oncol Clin North Am The pathogenesis of classical Hodgkin's lymphoma: a model for B-cell plasticity S. Mathas
November 01, 2010 / Cell Cycle Repeat-element driven activation of proto-oncogenes in human malignancies B. Lamprecht C. Bonifer S. Mathas
September 01, 2010 / Haematologica Common clonal origin of an acute B lymphoblastic leukemia and a Langerhans' cell sarcoma: evidence for hematopoietic plasticity R. Ratei M. Hummel I. Anagnostopoulos D. Jaehne R. Arnold B. Doerken S. Mathas B. Thomas O. Dudeck W.D. Ludwig H. Stein
May 01, 2010 / Nat Med Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma B. Lamprecht K. Walter S. Kreher R. Kumar M. Hummel D. Lenze K. Koechert M.A. Bouhlel J. Richter E. Soler R. Stadhouders K. Joehrens K.D. Wurster D.F. Callen M.F. Harte M. Giefing R. Barlow H. Stein I. Anagnostopoulos M. Janz P.N. Cockerill R. Siebert B. Doerken C. Bonifer S. Mathas
March 01, 2017 / Leukemia Inactivation of the putative ubiquitin-E3 ligase PDLIM2 in classical Hodgkin and anaplastic large cell lymphoma K.D. Wurster F. Hummel J. Richter M. Giefing S. Hartmann M.L. Hansmann S. Kreher K. Köchert D. Krappmann W. Klapper M. Hummel S.S. Wenzel G. Lenz M. Janz B. Dörken R. Siebert S. Mathas
January 05, 2017 / Blood Pharmacological restoration and therapeutic targeting of the B-cell phenotype in classical Hodgkin's lymphoma J. Du M. Neuenschwander Y. Yu J.H.M. Däbritz N.R. Neuendorff K. Schleich A. Bittner M. Milanovic G. Beuster S. Radetzki E. Specker M. Reimann F. Rosenbauer S. Mathas P. Lohneis M. Hummel B. Dörken J.P. von Kries S. Lee C.A. Schmitt
December 01, 2017 / Lancet Oncol Incorporation of brentuximab vedotin into first-line treatment of advanced classical Hodgkin's lymphoma: final analysis of a phase 2 randomised trial by the German Hodgkin Study Group D.A. Eichenauer A. Plütschow S. Kreissl M. Sökler J.C. Hellmuth J. Meissner S. Mathas M.S. Topp K. Behringer W. Klapper G. Kuhnert M. Dietlein C. Kobe M. Fuchs V. Diehl A. Engert P. Borchmann